• Caroline M Tanner.
• UCSF Weill Institute for Neurosciences, University of California, San Francisco, 212A Sandler Bldg, 675 Nelson Rising Lane, San Francisco, CA 94158.. Email: Caroline.Tanner@UCSF.edu.
• Am J Manag Care. 2020 Oct 1; 26 (12 Suppl): S255-S264.

AbstractParkinson disease, the second-most-common neurodegenerative disorder, affects approximately 1 million individuals in the United States, and this number is projected to increase to 1.2 million by 2030. Characterized pathologically by degeneration of dopaminergic neurons, with widespread pathology in nondopaminergic systems, Parkinson disease leads to an array of motor and nonmotor symptoms that can significantly impact an affected individual's quality of life. Treatments for Parkinson disease typically focus on controlling the motor symptoms of the disease, including treating OFF periods when motor symptoms return. OFF periods can occur for many individuals with Parkinson disease, especially as the disease progresses, and can pose a substantial burden to those with the disease and their caregivers. Available treatments for OFF periods may help alleviate this burden.

5 keywords...

hide…